Reuters logo
BRIEF-Immucell Corp sees FDA approval for Mast Out in 2019
October 11, 2016 / 3:56 PM / in a year

BRIEF-Immucell Corp sees FDA approval for Mast Out in 2019

Oct 11 (Reuters) - Immucell Corp

* Immucell Corp - U.S. FDA approval for co’s product Mast Out anticipated in 2019, allowing for two, six-month reviews of cmc technical section by FDA Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below